SCHEMBL6408024

SCHEMBL6408024

CC(C)(C)OC(=O)C1C(COC(c2ccccc2)(c2ccccc2)c2ccccc2)C1(C)C

nearest known ligand 0.36

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 1/20 0.36
HIF1A Q16665 1/20 0.36
ABCB1 P08183 1/20 0.35
KIF11 P52732 1/20 0.33
ELANE P08246 1/20 0.33
RECQL P46063 1/20 0.32
SLC6A1 P30531 1/20 0.32
KMT2A Q03164 3/20 0.32
MEN1 O00255 2/20 0.32
IDO1 P14902 1/20 0.32
HTT P42858 1/20 0.31
MAPT P10636 1/20 0.31
CA12 O43570 1/20 0.31
CA1 P00915 1/20 0.31
CA7 P43166 1/20 0.31
CA14 Q9ULX7 1/20 0.31
MAPK1 P28482 1/20 0.31
KCNA3 P22001 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6408835 0.92 SLC6A11 (0.41) KIF11RECQLSLC6A1KMT2AMEN1
SCHEMBL6414843 0.92 SLC6A11 (0.41) KIF11RECQLSLC6A1KMT2AMEN1
SCHEMBL6411212 0.86 HTT (0.41) CYP2C19KIF11ELANESLC6A1KMT2A
SCHEMBL6407457 0.86 ALDH1A1 (0.37) RECQLSLC6A1KMT2AMEN1MAPT
SCHEMBL6408280 0.85 SLC6A1 (0.38) CYP2C19HIF1AKIF11ELANESLC6A1
SCHEMBL6408302 0.84 MDM2 (0.42) CYP2C19KMT2AMEN1HTTMAPT
SCHEMBL6407236 0.80 SLC6A11 (0.43) KIF11RECQLSLC6A1KMT2AMEN1
SCHEMBL6412669 0.80 SLC6A11 (0.43) KIF11RECQLSLC6A1KMT2AMEN1
SCHEMBL6410838 0.79 FABP7 (0.41) CYP2C19SLC6A1
SCHEMBL6406120 0.79 L3MBTL1 (0.41) ABCB1CA12CA1CA7CA14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050288526-A1 Process for production of 2-(hydroxymethyl)cyclo-propanecarboxylic acids SUMITOMO CHEMICAL COMPAY LIMTED (JP) 2005-12-29 US disclosed
EP-1538141-A1 PROCESS FOR PRODUCTION OF 2-(HYDROXYMETHYL)CYCLO- PROPANECARBOXYLIC ACIDS Sumitomo Chemical Company, Limited (JP) 2005-06-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288526-A1 Process for production of 2-(hydroxymethyl)cyclo-propanecarboxylic acids GRHPR, PCCA, C5 CYP2C19 160/4885HIF1A 949/4885ABCB1 3851/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.